United States

Back to map

Showing 221-230 of 345 grants

Title Institution Researcher Program Duration Total Award Amount
Regenerable Reagentless Sensors for Continuous Monitoring of Insulin Northwestern University Shana Kelley Improving Lives 01-March-2026 to 29-February-2028 $348,937.89
Utilizing AI to Establish an Inception Cohort of Persons Living with Type 1 Diabetes Mellitus to Study Trajectories of Glycemic Variability and Related Risk Factors and Their Influence on Subsequent Risk of Cardiovascular Disease Northwestern University Sara Hassani Improving Lives 01-April-2026 to 31-March-2029 $1,014,920.00
Validation of a Tolerogenic Nanotherapy for Islet Transplantation in a Non-Human Primate Model Northwestern University Jacqueline Burke Cures 01-July-2023 to 30-June-2026 $998,275.64
Assessment of a Tolerogenic Nanoparticle in a Humanized Mouse Islet Transplantation Model Northwestern University Jacqueline Burke Cures 01-April-2024 to 31-March-2026 $499,746.76
A New Preparation of the Intact Eye for Measurements of Retinal Dysfunction in Acute Hyperglycemia and Early Diabetes Northwestern University Gregory Schwartz Improving Lives 01-October-2023 to 30-September-2026 $406,927.40
GPR75, a novel actor in beta cell regeneration New York Medical College Ercument Dirice Cures 01-April-2022 to 31-March-2027 $750,000.00
Preclinical evaluation of SERCA2 activators for pancreatic beta-cell protection in T1D Neurodon LLC Russell Dahl Cures 01-June-2022 to 31-May-2026 $920,000.00
Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare Nemours Children’s Clinic Jessica Pierce Improving Lives 01-May-2023 to 30-April-2028 $640,819.87
Anti-Serpin B13 Hu-mAb Lead Candidate Developability Assessment Mosaic Biosciences, Inc. Malavi Madireddi Cures 01-June-2025 to 22-July-2026 $293,674.00
Evaluating the Impact of High-Risk HLA-DR Serotypes on the Cellular Neighborhood of the Pancreatic Islets: Towards Early Identification of T1D Disease Risk and Prevention Missouri University of Science and Technology Gina Yosten Cures 01-October-2025 to 30-September-2028 $740,097.60